NOI to Sole Source: Super Script III Platinum One-Step qRT-PCR Kit
Closed Special Notice Posted
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- Place of performance
- San Juan, Puerto Rico, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has published a Special Notice announcing its intent to award a sole source, firm-fixed price purchase order to BioAnalytical Instruments, Inc. for the acquisition of SuperScript III Platinum One-Step qRT-PCR kits. These reagents have been approved by the FDA for the molecular diagnostic of several viruses, including SARS-CoV-2 and Zika, under Emergency Use Authorization.
The purpose of this Special Notice is to notify interested parties of the CDC's plan to procure these specialized reagents through a sole source contract action. Interested contractors have 15 days from the issuance of the notice to identify their interest and capability to respond to the requirement. However, this notice is not a request for competitive quotations, and the government reserves the sole discretion to determine whether to conduct a competitive procurement based on the responses received. Contractors are instructed to submit any quotations or responses to the designated contract specialist by the June 27, 2024 deadline. The sole source procurement is justified by the CDC due to the uniqueness of the required product and the urgency of the requirement.
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Bioanalytical Instruments, Inc. for SuperScript III Platinum One-Step qRT-PCR kits. The requested reagents, SuperScript III Platinum One-Step qRT-PCR, has been approved by the FDA for the molecular diagnostic of several viruses including SARS CoV-2 and Zika by PCR in clinical samples under Emergency Use Authorization. Bioanalytical Instruments, Inc. is currently the only local authorized distributor for the requested reagents. This contract action is for supplies for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at msipin@cdc.gov by COB 27 June 2024.
Files
| File | Type | Posted |
|---|---|---|
| SSJ BioAnalytical ICE Order for Signature v2 CO signed 13 June 2024.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity